nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—GPCR ligand binding—GRM1—epilepsy syndrome	0.00207	0.00423	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR3—epilepsy syndrome	0.00206	0.00421	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CNR1—epilepsy syndrome	0.00204	0.00415	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—NPY—epilepsy syndrome	0.00201	0.0041	CbGpPWpGaD
Bisacodyl—Brompheniramine—CHRM3—epilepsy syndrome	0.00198	0.189	CrCbGaD
Bisacodyl—GPR55—GPCR ligand binding—GAL—epilepsy syndrome	0.00195	0.00398	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—OXT—epilepsy syndrome	0.00194	0.00396	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL2—epilepsy syndrome	0.00194	0.00396	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL3—epilepsy syndrome	0.00194	0.00396	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CHRM3—epilepsy syndrome	0.00193	0.00393	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GRM5—epilepsy syndrome	0.00193	0.00393	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ACKR4—epilepsy syndrome	0.0019	0.00388	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.0019	0.00387	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.0019	0.00387	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.00185	0.00377	CbGpPWpGaD
Bisacodyl—Brompheniramine—CHRM1—epilepsy syndrome	0.00184	0.176	CrCbGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR10—epilepsy syndrome	0.00182	0.00371	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CHRM2—epilepsy syndrome	0.00181	0.0037	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.00181	0.0037	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.00181	0.0037	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GABBR1—epilepsy syndrome	0.00176	0.0036	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.00175	0.00358	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.00175	0.00358	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SSTR5—epilepsy syndrome	0.00172	0.00351	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SSTR4—epilepsy syndrome	0.00172	0.00351	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.00172	0.0035	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HRH3—epilepsy syndrome	0.00169	0.00345	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—OPRM1—epilepsy syndrome	0.00166	0.00339	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR10—epilepsy syndrome	0.00165	0.00337	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.00165	0.00336	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.00165	0.00336	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.00162	0.0033	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GRM2—epilepsy syndrome	0.00159	0.00324	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.00158	0.00322	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCR3—epilepsy syndrome	0.00157	0.0032	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—NPY—epilepsy syndrome	0.00153	0.00312	CbGpPWpGaD
Bisacodyl—Brompheniramine—CHRM2—epilepsy syndrome	0.00151	0.144	CrCbGaD
Bisacodyl—Anaphylactic shock—Midazolam—epilepsy syndrome	0.00149	0.00297	CcSEcCtD
Bisacodyl—Hypersensitivity—Rufinamide—epilepsy syndrome	0.00148	0.00297	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—OXT—epilepsy syndrome	0.00148	0.00301	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CRH—epilepsy syndrome	0.00148	0.00301	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL3—epilepsy syndrome	0.00148	0.00301	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL2—epilepsy syndrome	0.00148	0.00301	CbGpPWpGaD
Bisacodyl—Vomiting—Trimethadione—epilepsy syndrome	0.00147	0.00295	CcSEcCtD
Bisacodyl—Loss of consciousness—Diazepam—epilepsy syndrome	0.00146	0.00293	CcSEcCtD
Bisacodyl—Shock—Midazolam—epilepsy syndrome	0.00146	0.00293	CcSEcCtD
Bisacodyl—Muscle spasms—Clonazepam—epilepsy syndrome	0.00146	0.00293	CcSEcCtD
Bisacodyl—Nervous system disorder—Midazolam—epilepsy syndrome	0.00146	0.00292	CcSEcCtD
Bisacodyl—Muscle spasms—Phenytoin—epilepsy syndrome	0.00145	0.00291	CcSEcCtD
Bisacodyl—Headache—Trimethadione—epilepsy syndrome	0.00145	0.0029	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GRM2—epilepsy syndrome	0.00144	0.00294	CbGpPWpGaD
Bisacodyl—Malnutrition—Carbamazepine—epilepsy syndrome	0.00144	0.00289	CcSEcCtD
Bisacodyl—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.00144	0.00288	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.00144	0.00293	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR5—epilepsy syndrome	0.00142	0.0029	CbGpPWpGaD
Bisacodyl—Dehydration—Gabapentin—epilepsy syndrome	0.00142	0.00284	CcSEcCtD
Bisacodyl—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.00142	0.00283	CcSEcCtD
Bisacodyl—Syncope—Zonisamide—epilepsy syndrome	0.00141	0.00283	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.00141	0.00283	CcSEcCtD
Bisacodyl—Shock—Fosphenytoin—epilepsy syndrome	0.00139	0.00279	CcSEcCtD
Bisacodyl—Malnutrition—Lamotrigine—epilepsy syndrome	0.00139	0.00279	CcSEcCtD
Bisacodyl—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00139	0.00279	CcSEcCtD
Bisacodyl—Angioedema—Clonazepam—epilepsy syndrome	0.00139	0.00278	CcSEcCtD
Bisacodyl—Loss of consciousness—Zonisamide—epilepsy syndrome	0.00139	0.00278	CcSEcCtD
Bisacodyl—Muscle spasms—Carbamazepine—epilepsy syndrome	0.00139	0.00277	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.00138	0.00281	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.00138	0.00281	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR8—epilepsy syndrome	0.00138	0.00281	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.00138	0.00281	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR9—epilepsy syndrome	0.00138	0.00281	CbGpPWpGaD
Bisacodyl—Diarrhoea—Rufinamide—epilepsy syndrome	0.00138	0.00276	CcSEcCtD
Bisacodyl—Nausea—Trimethadione—epilepsy syndrome	0.00138	0.00275	CcSEcCtD
Bisacodyl—Angioedema—Oxcarbazepine—epilepsy syndrome	0.00137	0.00275	CcSEcCtD
Bisacodyl—Anaphylactic shock—Diazepam—epilepsy syndrome	0.00136	0.00272	CcSEcCtD
Bisacodyl—Dizziness—Phenobarbital—epilepsy syndrome	0.00136	0.00271	CcSEcCtD
Bisacodyl—Syncope—Phenytoin—epilepsy syndrome	0.00135	0.00271	CcSEcCtD
Bisacodyl—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.00135	0.00271	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GRM4—epilepsy syndrome	0.00135	0.00276	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GRM3—epilepsy syndrome	0.00135	0.00276	CbGpPWpGaD
Bisacodyl—Syncope—Oxcarbazepine—epilepsy syndrome	0.00135	0.0027	CcSEcCtD
Bisacodyl—Muscle spasms—Lamotrigine—epilepsy syndrome	0.00134	0.00268	CcSEcCtD
Bisacodyl—Shock—Diazepam—epilepsy syndrome	0.00134	0.00268	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCR2—epilepsy syndrome	0.00134	0.00272	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—SST—epilepsy syndrome	0.00134	0.00272	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Diazepam—epilepsy syndrome	0.00133	0.00267	CcSEcCtD
Bisacodyl—Dizziness—Rufinamide—epilepsy syndrome	0.00133	0.00266	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.00133	0.00271	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Phenytoin—epilepsy syndrome	0.00133	0.00266	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.00133	0.00271	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Oxcarbazepine—epilepsy syndrome	0.00132	0.00264	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—AGT—epilepsy syndrome	0.00132	0.00269	CbGpPWpGaD
Bisacodyl—Angioedema—Carbamazepine—epilepsy syndrome	0.00132	0.00264	CcSEcCtD
Bisacodyl—Anaphylactic shock—Felbamate—epilepsy syndrome	0.00132	0.00263	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.00131	0.00267	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SSTR3—epilepsy syndrome	0.0013	0.00266	CbGpPWpGaD
Bisacodyl—Vomiting—Phenobarbital—epilepsy syndrome	0.0013	0.00261	CcSEcCtD
Bisacodyl—Diarrhoea—Lacosamide—epilepsy syndrome	0.00129	0.00259	CcSEcCtD
Bisacodyl—Syncope—Carbamazepine—epilepsy syndrome	0.00129	0.00259	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.00129	0.00262	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRDM4—epilepsy syndrome	0.00129	0.00262	CbGpPWpGaD
Bisacodyl—Headache—Phenobarbital—epilepsy syndrome	0.00128	0.00257	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.00128	0.00257	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GRM8—epilepsy syndrome	0.00128	0.00261	CbGpPWpGaD
Bisacodyl—Vomiting—Rufinamide—epilepsy syndrome	0.00128	0.00256	CcSEcCtD
Bisacodyl—Angioedema—Lamotrigine—epilepsy syndrome	0.00127	0.00255	CcSEcCtD
Bisacodyl—Loss of consciousness—Carbamazepine—epilepsy syndrome	0.00127	0.00254	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.00127	0.00254	CcSEcCtD
Bisacodyl—Shock—Zonisamide—epilepsy syndrome	0.00127	0.00254	CcSEcCtD
Bisacodyl—Nervous system disorder—Zonisamide—epilepsy syndrome	0.00126	0.00253	CcSEcCtD
Bisacodyl—Headache—Rufinamide—epilepsy syndrome	0.00126	0.00252	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL12—epilepsy syndrome	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—Diarrhoea—Clobazam—epilepsy syndrome	0.00125	0.00251	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—NPY2R—epilepsy syndrome	0.00125	0.00255	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SSTR1—epilepsy syndrome	0.00125	0.00255	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR8—epilepsy syndrome	0.00125	0.00255	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR9—epilepsy syndrome	0.00125	0.00255	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.00125	0.00255	CbGpPWpGaD
Bisacodyl—Dizziness—Lacosamide—epilepsy syndrome	0.00125	0.0025	CcSEcCtD
Bisacodyl—Syncope—Lamotrigine—epilepsy syndrome	0.00125	0.0025	CcSEcCtD
Bisacodyl—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.00124	0.00248	CcSEcCtD
Bisacodyl—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00123	0.00247	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CNR1—epilepsy syndrome	0.00123	0.00251	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GRM4—epilepsy syndrome	0.00123	0.0025	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GRM3—epilepsy syndrome	0.00123	0.0025	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.00123	0.00245	CcSEcCtD
Bisacodyl—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.00122	0.00245	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.00122	0.00249	CbGpPWpGaD
Bisacodyl—Nausea—Phenobarbital—epilepsy syndrome	0.00122	0.00244	CcSEcCtD
Bisacodyl—Nervous system disorder—Clonazepam—epilepsy syndrome	0.00122	0.00244	CcSEcCtD
Bisacodyl—Dizziness—Clobazam—epilepsy syndrome	0.00121	0.00243	CcSEcCtD
Bisacodyl—Shock—Phenytoin—epilepsy syndrome	0.00121	0.00243	CcSEcCtD
Bisacodyl—Nervous system disorder—Phenytoin—epilepsy syndrome	0.00121	0.00242	CcSEcCtD
Bisacodyl—Shock—Oxcarbazepine—epilepsy syndrome	0.00121	0.00241	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—SSTR2—epilepsy syndrome	0.0012	0.00246	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR7—epilepsy syndrome	0.0012	0.00245	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.0012	0.00241	CcSEcCtD
Bisacodyl—Vomiting—Lacosamide—epilepsy syndrome	0.0012	0.00241	CcSEcCtD
Bisacodyl—Abdominal pain—Propofol—epilepsy syndrome	0.0012	0.0024	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.0012	0.0024	CcSEcCtD
Bisacodyl—Nausea—Rufinamide—epilepsy syndrome	0.0012	0.00239	CcSEcCtD
Bisacodyl—Dehydration—Topiramate—epilepsy syndrome	0.00119	0.00239	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.00119	0.00239	CcSEcCtD
Bisacodyl—Headache—Lacosamide—epilepsy syndrome	0.00118	0.00237	CcSEcCtD
Bisacodyl—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.00118	0.00236	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.00117	0.00235	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR7—epilepsy syndrome	0.00117	0.00239	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PDYN—epilepsy syndrome	0.00117	0.00239	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GRM1—epilepsy syndrome	0.00117	0.00239	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.00117	0.00239	CbGpPWpGaD
Bisacodyl—Vomiting—Clobazam—epilepsy syndrome	0.00117	0.00233	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GRM8—epilepsy syndrome	0.00116	0.00237	CbGpPWpGaD
Bisacodyl—Abdominal pain—Levetiracetam—epilepsy syndrome	0.00116	0.00232	CcSEcCtD
Bisacodyl—Shock—Carbamazepine—epilepsy syndrome	0.00116	0.00232	CcSEcCtD
Bisacodyl—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.00115	0.00231	CcSEcCtD
Bisacodyl—Headache—Clobazam—epilepsy syndrome	0.00115	0.0023	CcSEcCtD
Bisacodyl—Immune system disorder—Valproic Acid—epilepsy syndrome	0.00115	0.0023	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.00113	0.00231	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.00113	0.00226	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ACKR4—epilepsy syndrome	0.00112	0.00229	CbGpPWpGaD
Bisacodyl—Nausea—Lacosamide—epilepsy syndrome	0.00112	0.00225	CcSEcCtD
Bisacodyl—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00112	0.00224	CcSEcCtD
Bisacodyl—Shock—Lamotrigine—epilepsy syndrome	0.00112	0.00224	CcSEcCtD
Bisacodyl—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00111	0.00223	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.00111	0.00222	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.00111	0.00222	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—POMC—epilepsy syndrome	0.00111	0.00227	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNAO1—epilepsy syndrome	0.00111	0.00226	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—OPRD1—epilepsy syndrome	0.00111	0.00226	CbGpPWpGaD
Bisacodyl—Malnutrition—Valproic Acid—epilepsy syndrome	0.00111	0.00222	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.00111	0.00226	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GAL—epilepsy syndrome	0.0011	0.00225	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Midazolam—epilepsy syndrome	0.00109	0.00219	CcSEcCtD
Bisacodyl—Abdominal pain—Vigabatrin—epilepsy syndrome	0.00109	0.00218	CcSEcCtD
Bisacodyl—Nausea—Clobazam—epilepsy syndrome	0.00109	0.00218	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GRM5—epilepsy syndrome	0.00109	0.00222	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.00109	0.00222	CbGpPWpGaD
Bisacodyl—Dizziness—Acetazolamide—epilepsy syndrome	0.00108	0.00216	CcSEcCtD
Bisacodyl—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00108	0.00216	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.00108	0.00215	CcSEcCtD
Bisacodyl—Abdominal pain—Diazepam—epilepsy syndrome	0.00107	0.00215	CcSEcCtD
Bisacodyl—Carbinoxamine—CYP2C19—epilepsy syndrome	0.00107	0.103	CrCbGaD
Bisacodyl—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.00107	0.00214	CcSEcCtD
Bisacodyl—Muscle spasms—Valproic Acid—epilepsy syndrome	0.00106	0.00213	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.00106	0.00213	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GRM1—epilepsy syndrome	0.00106	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR7—epilepsy syndrome	0.00106	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CHRM1—epilepsy syndrome	0.00106	0.00217	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PDYN—epilepsy syndrome	0.00106	0.00217	CbGpPWpGaD
Bisacodyl—Abdominal discomfort—Topiramate—epilepsy syndrome	0.00106	0.00213	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.00106	0.00212	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.00105	0.00211	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.00105	0.00214	CbGpPWpGaD
Bisacodyl—Abdominal pain—Felbamate—epilepsy syndrome	0.00104	0.00208	CcSEcCtD
Bisacodyl—Vomiting—Acetazolamide—epilepsy syndrome	0.00104	0.00208	CcSEcCtD
Bisacodyl—Diarrhoea—Propofol—epilepsy syndrome	0.00104	0.00208	CcSEcCtD
Bisacodyl—Immune system disorder—Pregabalin—epilepsy syndrome	0.00104	0.00208	CcSEcCtD
Bisacodyl—Headache—Acetazolamide—epilepsy syndrome	0.00102	0.00205	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.00102	0.00209	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.00102	0.00209	CbGpPWpGaD
Bisacodyl—Abdominal pain—Zonisamide—epilepsy syndrome	0.00102	0.00204	CcSEcCtD
Bisacodyl—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00102	0.00204	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SSTR4—epilepsy syndrome	0.00102	0.00207	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SSTR5—epilepsy syndrome	0.00102	0.00207	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.00102	0.00203	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.00101	0.00203	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—AVP—epilepsy syndrome	0.00101	0.00206	CbGpPWpGaD
Bisacodyl—Angioedema—Valproic Acid—epilepsy syndrome	0.00101	0.00202	CcSEcCtD
Bisacodyl—Dizziness—Propofol—epilepsy syndrome	0.001	0.00201	CcSEcCtD
Bisacodyl—Diarrhoea—Levetiracetam—epilepsy syndrome	0.001	0.00201	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.001	0.00201	CcSEcCtD
Bisacodyl—Hypersensitivity—Diazepam—epilepsy syndrome	0.001	0.002	CcSEcCtD
Bisacodyl—Malnutrition—Pregabalin—epilepsy syndrome	0.001	0.002	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GAL—epilepsy syndrome	0.001	0.00204	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000996	0.00203	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000989	0.00202	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GRM5—epilepsy syndrome	0.000989	0.00202	CbGpPWpGaD
Bisacodyl—Dizziness—Midazolam—epilepsy syndrome	0.000982	0.00197	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000981	0.00197	CcSEcCtD
Bisacodyl—Abdominal pain—Clonazepam—epilepsy syndrome	0.000981	0.00196	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR10—epilepsy syndrome	0.000975	0.00199	CbGpPWpGaD
Bisacodyl—Nausea—Acetazolamide—epilepsy syndrome	0.000971	0.00194	CcSEcCtD
Bisacodyl—Dizziness—Levetiracetam—epilepsy syndrome	0.00097	0.00194	CcSEcCtD
Bisacodyl—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000969	0.00194	CcSEcCtD
Bisacodyl—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000969	0.00194	CcSEcCtD
Bisacodyl—Vomiting—Propofol—epilepsy syndrome	0.000965	0.00193	CcSEcCtD
Bisacodyl—Chlorphenamine—SLC6A4—epilepsy syndrome	0.000962	0.0921	CrCbGaD
Bisacodyl—Muscle spasms—Pregabalin—epilepsy syndrome	0.000962	0.00193	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000962	0.00193	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000955	0.00195	CbGpPWpGaD
Bisacodyl—Immune system disorder—Gabapentin—epilepsy syndrome	0.000952	0.00191	CcSEcCtD
Bisacodyl—Headache—Propofol—epilepsy syndrome	0.000951	0.0019	CcSEcCtD
Bisacodyl—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000948	0.0019	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000948	0.00193	CbGpPWpGaD
Bisacodyl—Vomiting—Midazolam—epilepsy syndrome	0.000945	0.00189	CcSEcCtD
Bisacodyl—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000944	0.00189	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.00094	0.00192	CbGpPWpGaD
Bisacodyl—Dizziness—Fosphenytoin—epilepsy syndrome	0.000936	0.00187	CcSEcCtD
Bisacodyl—Vomiting—Levetiracetam—epilepsy syndrome	0.000933	0.00187	CcSEcCtD
Bisacodyl—Headache—Midazolam—epilepsy syndrome	0.000931	0.00186	CcSEcCtD
Bisacodyl—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00093	0.00186	CcSEcCtD
Bisacodyl—Diarrhoea—Diazepam—epilepsy syndrome	0.00093	0.00186	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.00093	0.00186	CcSEcCtD
Bisacodyl—Brompheniramine—CYP2C19—epilepsy syndrome	0.00093	0.0889	CrCbGaD
Bisacodyl—GPR55—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000929	0.0019	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000929	0.0019	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000929	0.0019	CbGpPWpGaD
Bisacodyl—Headache—Levetiracetam—epilepsy syndrome	0.000919	0.00184	CcSEcCtD
Bisacodyl—Malnutrition—Gabapentin—epilepsy syndrome	0.000918	0.00184	CcSEcCtD
Bisacodyl—Angioedema—Pregabalin—epilepsy syndrome	0.000914	0.00183	CcSEcCtD
Bisacodyl—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000914	0.00183	CcSEcCtD
Bisacodyl—Dizziness—Vigabatrin—epilepsy syndrome	0.000913	0.00183	CcSEcCtD
Bisacodyl—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000908	0.00182	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000904	0.00184	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000903	0.00181	CcSEcCtD
Bisacodyl—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000903	0.00181	CcSEcCtD
Bisacodyl—Nausea—Propofol—epilepsy syndrome	0.000902	0.00181	CcSEcCtD
Bisacodyl—Vomiting—Fosphenytoin—epilepsy syndrome	0.0009	0.0018	CcSEcCtD
Bisacodyl—Diarrhoea—Felbamate—epilepsy syndrome	0.0009	0.0018	CcSEcCtD
Bisacodyl—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000899	0.0018	CcSEcCtD
Bisacodyl—Dizziness—Diazepam—epilepsy syndrome	0.000899	0.0018	CcSEcCtD
Bisacodyl—Syncope—Pregabalin—epilepsy syndrome	0.000897	0.0018	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000887	0.00181	CbGpPWpGaD
Bisacodyl—Headache—Fosphenytoin—epilepsy syndrome	0.000887	0.00178	CcSEcCtD
Bisacodyl—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000886	0.00177	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000883	0.0018	CbGpPWpGaD
Bisacodyl—Nausea—Midazolam—epilepsy syndrome	0.000882	0.00177	CcSEcCtD
Bisacodyl—Muscle spasms—Gabapentin—epilepsy syndrome	0.000882	0.00177	CcSEcCtD
Bisacodyl—Diarrhoea—Zonisamide—epilepsy syndrome	0.000881	0.00176	CcSEcCtD
Bisacodyl—Loss of consciousness—Pregabalin—epilepsy syndrome	0.00088	0.00176	CcSEcCtD
Bisacodyl—Vomiting—Vigabatrin—epilepsy syndrome	0.000878	0.00176	CcSEcCtD
Bisacodyl—Nausea—Levetiracetam—epilepsy syndrome	0.000871	0.00174	CcSEcCtD
Bisacodyl—Dizziness—Felbamate—epilepsy syndrome	0.00087	0.00174	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HRH3—epilepsy syndrome	0.000867	0.00177	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000867	0.00174	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—NPY—epilepsy syndrome	0.000865	0.00176	CbGpPWpGaD
Bisacodyl—Headache—Vigabatrin—epilepsy syndrome	0.000865	0.00173	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000864	0.00176	CbGpPWpGaD
Bisacodyl—Vomiting—Diazepam—epilepsy syndrome	0.000864	0.00173	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCR5—epilepsy syndrome	0.00086	0.00176	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000853	0.00174	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GRM2—epilepsy syndrome	0.000852	0.00174	CbGpPWpGaD
Bisacodyl—Dizziness—Zonisamide—epilepsy syndrome	0.000851	0.0017	CcSEcCtD
Bisacodyl—Headache—Diazepam—epilepsy syndrome	0.000851	0.0017	CcSEcCtD
Bisacodyl—Diarrhoea—Clonazepam—epilepsy syndrome	0.000849	0.0017	CcSEcCtD
Bisacodyl—Diarrhoea—Phenytoin—epilepsy syndrome	0.000843	0.00169	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000842	0.00172	CbGpPWpGaD
Bisacodyl—Nausea—Fosphenytoin—epilepsy syndrome	0.000841	0.00168	CcSEcCtD
Bisacodyl—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000839	0.00168	CcSEcCtD
Bisacodyl—Angioedema—Gabapentin—epilepsy syndrome	0.000838	0.00168	CcSEcCtD
Bisacodyl—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000838	0.00168	CcSEcCtD
Bisacodyl—Vomiting—Felbamate—epilepsy syndrome	0.000836	0.00167	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000834	0.0017	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—OXT—epilepsy syndrome	0.000834	0.0017	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CRH—epilepsy syndrome	0.000834	0.0017	CbGpPWpGaD
Bisacodyl—Headache—Felbamate—epilepsy syndrome	0.000824	0.00165	CcSEcCtD
Bisacodyl—Syncope—Gabapentin—epilepsy syndrome	0.000823	0.00165	CcSEcCtD
Bisacodyl—Dizziness—Clonazepam—epilepsy syndrome	0.00082	0.00164	CcSEcCtD
Bisacodyl—Nausea—Vigabatrin—epilepsy syndrome	0.00082	0.00164	CcSEcCtD
Bisacodyl—Vomiting—Zonisamide—epilepsy syndrome	0.000818	0.00164	CcSEcCtD
Bisacodyl—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000817	0.00164	CcSEcCtD
Bisacodyl—Dizziness—Phenytoin—epilepsy syndrome	0.000815	0.00163	CcSEcCtD
Bisacodyl—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000811	0.00162	CcSEcCtD
Bisacodyl—Nausea—Diazepam—epilepsy syndrome	0.000807	0.00162	CcSEcCtD
Bisacodyl—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000807	0.00161	CcSEcCtD
Bisacodyl—Headache—Zonisamide—epilepsy syndrome	0.000806	0.00161	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR3—epilepsy syndrome	0.000806	0.00164	CbGpPWpGaD
Bisacodyl—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000805	0.00161	CcSEcCtD
Bisacodyl—Shock—Pregabalin—epilepsy syndrome	0.000803	0.00161	CcSEcCtD
Bisacodyl—Immune system disorder—Topiramate—epilepsy syndrome	0.000801	0.0016	CcSEcCtD
Bisacodyl—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000801	0.0016	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—AGT—epilepsy syndrome	0.000799	0.00163	CbGpPWpGaD
Bisacodyl—Carbinoxamine—CYP2D6—epilepsy syndrome	0.000796	0.0761	CrCbGaD
Bisacodyl—Vomiting—Clonazepam—epilepsy syndrome	0.000789	0.00158	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—NPY—epilepsy syndrome	0.000785	0.0016	CbGpPWpGaD
Bisacodyl—Vomiting—Phenytoin—epilepsy syndrome	0.000784	0.00157	CcSEcCtD
Bisacodyl—Nausea—Felbamate—epilepsy syndrome	0.000781	0.00156	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.00078	0.00156	CcSEcCtD
Bisacodyl—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000779	0.00156	CcSEcCtD
Bisacodyl—Dizziness—Carbamazepine—epilepsy syndrome	0.000778	0.00156	CcSEcCtD
Bisacodyl—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000778	0.00156	CcSEcCtD
Bisacodyl—Headache—Clonazepam—epilepsy syndrome	0.000777	0.00156	CcSEcCtD
Bisacodyl—Headache—Phenytoin—epilepsy syndrome	0.000772	0.00155	CcSEcCtD
Bisacodyl—Malnutrition—Topiramate—epilepsy syndrome	0.000772	0.00155	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SSTR3—epilepsy syndrome	0.000771	0.00157	CbGpPWpGaD
Bisacodyl—Headache—Oxcarbazepine—epilepsy syndrome	0.000768	0.00154	CcSEcCtD
Bisacodyl—Nausea—Zonisamide—epilepsy syndrome	0.000765	0.00153	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000758	0.00155	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL3—epilepsy syndrome	0.000758	0.00155	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CRH—epilepsy syndrome	0.000758	0.00155	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—OXT—epilepsy syndrome	0.000758	0.00155	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000755	0.00154	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—SST—epilepsy syndrome	0.000755	0.00154	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000754	0.00154	CbGpPWpGaD
Bisacodyl—Dizziness—Lamotrigine—epilepsy syndrome	0.000752	0.00151	CcSEcCtD
Bisacodyl—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000749	0.0015	CcSEcCtD
Bisacodyl—Vomiting—Carbamazepine—epilepsy syndrome	0.000748	0.0015	CcSEcCtD
Bisacodyl—Muscle spasms—Topiramate—epilepsy syndrome	0.000742	0.00149	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000739	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR8—epilepsy syndrome	0.000739	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR9—epilepsy syndrome	0.000739	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY2R—epilepsy syndrome	0.000739	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SSTR1—epilepsy syndrome	0.000739	0.00151	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000739	0.00148	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000738	0.00151	CbGpPWpGaD
Bisacodyl—Nausea—Clonazepam—epilepsy syndrome	0.000737	0.00148	CcSEcCtD
Bisacodyl—Headache—Carbamazepine—epilepsy syndrome	0.000737	0.00148	CcSEcCtD
Bisacodyl—Shock—Gabapentin—epilepsy syndrome	0.000737	0.00148	CcSEcCtD
Bisacodyl—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000734	0.00147	CcSEcCtD
Bisacodyl—Nausea—Phenytoin—epilepsy syndrome	0.000732	0.00147	CcSEcCtD
Bisacodyl—Nausea—Oxcarbazepine—epilepsy syndrome	0.000728	0.00146	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GRM3—epilepsy syndrome	0.000724	0.00148	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GRM4—epilepsy syndrome	0.000724	0.00148	CbGpPWpGaD
Bisacodyl—Vomiting—Lamotrigine—epilepsy syndrome	0.000723	0.00145	CcSEcCtD
Bisacodyl—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000714	0.00143	CcSEcCtD
Bisacodyl—Headache—Lamotrigine—epilepsy syndrome	0.000712	0.00143	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SSTR2—epilepsy syndrome	0.000711	0.00145	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DUSP4—epilepsy syndrome	0.000711	0.00145	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000709	0.00145	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000709	0.00145	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000705	0.00141	CcSEcCtD
Bisacodyl—Nausea—Carbamazepine—epilepsy syndrome	0.000699	0.0014	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000696	0.00142	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000694	0.00142	CbGpPWpGaD
Bisacodyl—Syncope—Topiramate—epilepsy syndrome	0.000692	0.00139	CcSEcCtD
Bisacodyl—Brompheniramine—CYP2D6—epilepsy syndrome	0.000689	0.0659	CrCbGaD
Bisacodyl—GPR55—Signaling Pathways—GRM8—epilepsy syndrome	0.000687	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PGF—epilepsy syndrome	0.000687	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SST—epilepsy syndrome	0.000685	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR2—epilepsy syndrome	0.000685	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000679	0.00139	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Topiramate—epilepsy syndrome	0.000679	0.00136	CcSEcCtD
Bisacodyl—Chlorphenamine—CYP2D6—epilepsy syndrome	0.000676	0.0647	CrCbGaD
Bisacodyl—Nausea—Lamotrigine—epilepsy syndrome	0.000675	0.00135	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—POMC—epilepsy syndrome	0.000672	0.00137	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000671	0.00137	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000668	0.00134	CcSEcCtD
Bisacodyl—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000666	0.00133	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL2—epilepsy syndrome	0.000658	0.00134	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNAO1—epilepsy syndrome	0.000655	0.00134	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—OPRD1—epilepsy syndrome	0.000655	0.00134	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000647	0.00132	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000647	0.00129	CcSEcCtD
Bisacodyl—Abdominal pain—Pregabalin—epilepsy syndrome	0.000646	0.00129	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000644	0.00131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000644	0.00131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CNR1—epilepsy syndrome	0.000632	0.00129	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PLCB1—epilepsy syndrome	0.00063	0.00129	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDYN—epilepsy syndrome	0.000628	0.00128	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GRM1—epilepsy syndrome	0.000628	0.00128	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CHRM1—epilepsy syndrome	0.000628	0.00128	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR7—epilepsy syndrome	0.000628	0.00128	CbGpPWpGaD
Bisacodyl—Shock—Topiramate—epilepsy syndrome	0.00062	0.00124	CcSEcCtD
Bisacodyl—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000618	0.00124	CcSEcCtD
Bisacodyl—Nervous system disorder—Topiramate—epilepsy syndrome	0.000618	0.00124	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HTR7—epilepsy syndrome	0.000617	0.00126	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000612	0.00123	CcSEcCtD
Bisacodyl—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000602	0.0012	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000599	0.00122	CbGpPWpGaD
Bisacodyl—Dizziness—Valproic Acid—epilepsy syndrome	0.000597	0.0012	CcSEcCtD
Bisacodyl—Abdominal pain—Gabapentin—epilepsy syndrome	0.000592	0.00119	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000591	0.00121	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GAL—epilepsy syndrome	0.000591	0.00121	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GFAP—epilepsy syndrome	0.000591	0.00121	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT3—epilepsy syndrome	0.000588	0.0012	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CASP2—epilepsy syndrome	0.000584	0.00119	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CHRM3—epilepsy syndrome	0.000584	0.00119	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GRM5—epilepsy syndrome	0.000584	0.00119	CbGpPWpGaD
Bisacodyl—Vomiting—Valproic Acid—epilepsy syndrome	0.000574	0.00115	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AVP—epilepsy syndrome	0.000572	0.00117	CbGpPWpGaD
Bisacodyl—Headache—Valproic Acid—epilepsy syndrome	0.000566	0.00113	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CX3CR1—epilepsy syndrome	0.00056	0.00114	CbGpPWpGaD
Bisacodyl—Diarrhoea—Pregabalin—epilepsy syndrome	0.000559	0.00112	CcSEcCtD
Bisacodyl—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000552	0.0011	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000549	0.00112	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CHRM2—epilepsy syndrome	0.000549	0.00112	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000549	0.00112	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000544	0.00109	CcSEcCtD
Bisacodyl—Dizziness—Pregabalin—epilepsy syndrome	0.00054	0.00108	CcSEcCtD
Bisacodyl—Nausea—Valproic Acid—epilepsy syndrome	0.000537	0.00107	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CDC42—epilepsy syndrome	0.000536	0.00109	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GABBR1—epilepsy syndrome	0.000534	0.00109	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AVP—epilepsy syndrome	0.000519	0.00106	CbGpPWpGaD
Bisacodyl—Vomiting—Pregabalin—epilepsy syndrome	0.000519	0.00104	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000515	0.00103	CcSEcCtD
Bisacodyl—Diarrhoea—Gabapentin—epilepsy syndrome	0.000512	0.00103	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—HRH3—epilepsy syndrome	0.000512	0.00104	CbGpPWpGaD
Bisacodyl—Headache—Pregabalin—epilepsy syndrome	0.000512	0.00102	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—OPRM1—epilepsy syndrome	0.000504	0.00103	CbGpPWpGaD
Bisacodyl—Abdominal pain—Topiramate—epilepsy syndrome	0.000498	0.000997	CcSEcCtD
Bisacodyl—Dizziness—Gabapentin—epilepsy syndrome	0.000495	0.000991	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000486	0.000992	CbGpPWpGaD
Bisacodyl—Nausea—Pregabalin—epilepsy syndrome	0.000485	0.000971	CcSEcCtD
Bisacodyl—Vomiting—Gabapentin—epilepsy syndrome	0.000476	0.000953	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR3—epilepsy syndrome	0.000476	0.000971	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000476	0.000971	CbGpPWpGaD
Bisacodyl—Headache—Gabapentin—epilepsy syndrome	0.000469	0.000939	CcSEcCtD
Bisacodyl—Hypersensitivity—Topiramate—epilepsy syndrome	0.000464	0.000929	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NPY—epilepsy syndrome	0.000464	0.000947	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000464	0.000947	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AGT—epilepsy syndrome	0.000451	0.000921	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HSPB1—epilepsy syndrome	0.000448	0.000913	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CRH—epilepsy syndrome	0.000448	0.000913	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL2—epilepsy syndrome	0.000448	0.000913	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL3—epilepsy syndrome	0.000448	0.000913	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—OXT—epilepsy syndrome	0.000448	0.000913	CbGpPWpGaD
Bisacodyl—Nausea—Gabapentin—epilepsy syndrome	0.000445	0.000891	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR5—epilepsy syndrome	0.000442	0.000901	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000432	0.000882	CbGpPWpGaD
Bisacodyl—Diarrhoea—Topiramate—epilepsy syndrome	0.000431	0.000863	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000417	0.000851	CbGpPWpGaD
Bisacodyl—Dizziness—Topiramate—epilepsy syndrome	0.000417	0.000834	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PTK2B—epilepsy syndrome	0.000416	0.000849	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TSC1—epilepsy syndrome	0.000416	0.000849	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AGT—epilepsy syndrome	0.00041	0.000837	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR2—epilepsy syndrome	0.000405	0.000826	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NTRK2—epilepsy syndrome	0.000405	0.000826	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SST—epilepsy syndrome	0.000405	0.000826	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DUSP6—epilepsy syndrome	0.000401	0.000819	CbGpPWpGaD
Bisacodyl—Vomiting—Topiramate—epilepsy syndrome	0.000401	0.000802	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000396	0.000808	CbGpPWpGaD
Bisacodyl—Headache—Topiramate—epilepsy syndrome	0.000395	0.00079	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PLAT—epilepsy syndrome	0.000394	0.000805	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000381	0.000777	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL12—epilepsy syndrome	0.000381	0.000777	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—POMC—epilepsy syndrome	0.00038	0.000775	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000379	0.000773	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000377	0.00077	CbGpPWpGaD
Bisacodyl—Nausea—Topiramate—epilepsy syndrome	0.000374	0.000749	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—JUNB—epilepsy syndrome	0.000374	0.000762	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CNR1—epilepsy syndrome	0.000374	0.000762	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLCB1—epilepsy syndrome	0.000372	0.00076	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR7—epilepsy syndrome	0.000364	0.000744	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HBEGF—epilepsy syndrome	0.000354	0.000722	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT3—epilepsy syndrome	0.000347	0.000709	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—POMC—epilepsy syndrome	0.000345	0.000704	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADAM10—epilepsy syndrome	0.000339	0.000692	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL2—epilepsy syndrome	0.000338	0.000689	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—S100B—epilepsy syndrome	0.000321	0.000655	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS3—epilepsy syndrome	0.000318	0.000648	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CDC42—epilepsy syndrome	0.000317	0.000647	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AVP—epilepsy syndrome	0.000307	0.000626	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HES1—epilepsy syndrome	0.00029	0.000592	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FYN—epilepsy syndrome	0.000282	0.000576	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—H2AFX—epilepsy syndrome	0.000281	0.000574	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MEF2C—epilepsy syndrome	0.000281	0.000573	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000271	0.000553	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NGF—epilepsy syndrome	0.000268	0.000547	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR5—epilepsy syndrome	0.000261	0.000532	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR2A—epilepsy syndrome	0.000255	0.000521	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TSC2—epilepsy syndrome	0.000242	0.000495	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGT—epilepsy syndrome	0.000242	0.000494	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOE—epilepsy syndrome	0.000237	0.000484	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KDR—epilepsy syndrome	0.000232	0.000474	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKCB—epilepsy syndrome	0.000224	0.000457	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6ST—epilepsy syndrome	0.000223	0.000455	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—POMC—epilepsy syndrome	0.000204	0.000416	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL2—epilepsy syndrome	0.000199	0.000407	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF2—epilepsy syndrome	0.00018	0.000368	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RELA—epilepsy syndrome	0.000167	0.000341	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MTOR—epilepsy syndrome	0.000164	0.000335	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT1—epilepsy syndrome	0.000152	0.000311	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CASP3—epilepsy syndrome	0.000151	0.000308	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JUN—epilepsy syndrome	0.000147	0.000299	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MMP9—epilepsy syndrome	0.000143	0.000291	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT1—epilepsy syndrome	0.000138	0.000282	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SRC—epilepsy syndrome	0.000132	0.000268	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—VEGFA—epilepsy syndrome	0.000128	0.000261	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT1—epilepsy syndrome	8.17e-05	0.000167	CbGpPWpGaD
